Reduction of iatrogenic RPE lesions in AMD patients: evidence for wound healing?

Doris Rabenlehner1, Boris V Stanzel, Ilse Krebs

  • 1The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery, Vienna, Austria. doris.rabenlehner@mediatrain.at

Abstract

Insights

Retinal pigment epithelium (RPE) wound healing in age-related macular degeneration (AMD) patients shows partial recovery in nearly half of cases. This RPE healing process appears to stabilize after two months post-surgery.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine

Background:

  • Age-related macular degeneration (AMD) poses significant challenges to retinal health.
  • Retinal pigment epithelium (RPE) defects can result from AMD treatments.
  • Understanding RPE wound healing is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the wound healing process of the retinal pigment epithelium (RPE) in patients diagnosed with age-related macular degeneration (AMD).

Main Methods:

  • Abrasive debridement of nasal RPE was performed during pars plana vitrectomy for choroidal neovascularization (CNV) excision and autologous RPE transplantation.
  • Serial imaging (fundus autofluorescence, fluorescein angiography, red-free) was conducted postoperatively for up to 6 months.
  • Lesion areas were measured and analyzed using ArchiCad Software in 14 AMD patients.

Main Results:

  • 42.9% of patients exhibited a reduction in the debrided RPE area.
  • Lesion sizes decreased by 5.6-20% within the first two postoperative months.
  • No further significant RPE lesion size reduction was observed after two months; borders remained stable in eight cases.

Conclusions:

  • Wound healing of debrided RPE monolayer defects in AMD patients occurs to a limited extent in approximately half of the cases.
  • The RPE healing process appears to reach a plateau approximately two months after the surgical intervention.

Related Concept Videos